GEODE CAPITAL MANAGEMENT, LLC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2023$47,180
-19.8%
36,2930.0%0.00%
Q2 2023$58,794
-23.9%
36,2930.0%0.00%
Q1 2023$77,304
+57589.6%
36,2930.0%0.00%
Q4 2022$134
-99.5%
36,2930.0%0.00%
Q3 2022$27,000
-3.6%
36,2930.0%0.00%
Q2 2022$28,000
-12.5%
36,2930.0%0.00%
Q1 2022$32,000
-89.0%
36,2930.0%0.00%
Q4 2021$290,000
-4.3%
36,2930.0%0.00%
Q3 2021$303,000
+77.2%
36,293
+42.9%
0.00%
Q2 2021$171,000
+32.6%
25,405
+30.1%
0.00%
Q1 2021$129,000
+130.4%
19,532
+45.9%
0.00%
Q4 2020$56,000
-80.0%
13,384
-77.1%
0.00%
Q3 2020$280,000
-16.7%
58,545
+5.6%
0.00%
Q2 2020$336,000
+13.9%
55,421
+2.8%
0.00%
Q1 2020$295,000
-71.9%
53,911
-49.2%
0.00%
Q4 2019$1,050,000
+521.3%
106,142
+259.7%
0.00%
Q3 2019$169,000
-36.9%
29,5110.0%0.00%
Q2 2019$268,000
-34.5%
29,5110.0%0.00%
Q1 2019$409,000
-32.3%
29,511
-23.1%
0.00%
Q4 2018$604,000
+85.8%
38,386
+128.2%
0.00%
Q3 2018$325,000
+301.2%
16,818
+50.9%
0.00%
Q2 2018$81,000
+37.3%
11,148
-8.7%
0.00%
Q3 2017$59,000
-11.9%
12,211
-6.0%
0.00%
Q2 2017$67,000
+17.5%
12,997
+12.2%
0.00%
Q1 2017$57,000
+3.6%
11,588
+3.2%
0.00%
Q4 2016$55,000
-24.7%
11,234
+2.1%
0.00%
Q3 2016$73,000
+40.4%
10,998
+0.5%
0.00%
Q2 2016$52,00010,9390.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders